Research into the most prevalent tumors in developing countries significantly lags behind research into those cancers that ...

Fintel reports that on May 16, 2025, UBS downgraded their outlook for Iovance Biotherapeutics (NasdaqGM:IOVA) from Buy to ...

If there is one disease in our time that we have become accustomed to living with, it is cancer. This condition has unfortunately seen a 3.3% increase in cases so far in 2025 compa ...

When Sydney Hewit left her Jane Austin literature class at University of Vermont in January and headed for the Emergency ...

Eisai retains exclusive development and marketing rights for the agent in Japan and Asia.

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

Three children have died in the most recent outbreak of measles. This article reviews the symptoms and treatment of measles.

A systematic review and subsequent expert review gave comprehensive insight into prognostic factors for patients receiving ...

A recent study from ‘Nature’ is flashing a warning sign on certain energy drinks, with their study linking taurine, one of ...

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer and the fourth leading cause of cancer-related death, has a 5-year survival rate of less than 10%.1 The impact of pancreatic ...

Aggressive blood cancers all originate in the bone marrow, where the research shows cancer cells depend on the ingredient ...